/
JYNT
$8.33-$0.19 (-2.23%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$121.5M
14M shares
52-week range
$7.50 – $12.27
17% from low
Sector
PATENT OWNERS & LESSORS
Exchange
NASDAQ
CS
Borrow rate
2.38%
Moderate
Price (6 mo)
Loading chart…
Change$-76.67
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $31.8M | $48.5M | $58.7M | $80.0M | $101.3M | $47.0M | $52.2M | $54.9M |
| Cost of revenue | $4.3M | $5.6M | $6.5M | $7.7M | $9.2M | $10.5M | $11.5M | $11.2M |
| Gross profit | $27.5M | $42.9M | $52.2M | $72.3M | $92.1M | $36.5M | $40.6M | $43.7M |
| Gross margin | 86.4% | 88.5% | 88.9% | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| R&D | $343.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $205.1K | $3.4M | $5.5M | $6.1M | $828.3K | $318.3K | −$1.9M | −$905.5K |
| EBITDA | $2.3M | $5.4M | $8.2M | $10.1M | $7.9M | $8.9M | $2.9M | $1.5M |
| Net income | $253.1K | $3.3M | $13.2M | $7.6M | $626.7K | −$9.8M | −$5.8M | $2.9M |
| Net margin | 0.8% | 6.9% | 22.4% | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (diluted) | 0.02 | 0.23 | 0.90 | 0.44 | 0.04 | -0.66 | -0.39 | 0.19 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $60M | $0.28 | $0.23–$0.32 | 2 |
| 2027 | $62M | $0.30 | $0.28–$0.33 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$2.71
Price
$8.33
Implied downside
-67%
Peer comparison
The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
www.thejoint.com- Employees
- 330
- IPO / List date
- Nov 11, 2014
- HQ
- SCOTTSDALE, AZ
Held by traders on TradeandTell
No one on the platform currently holds JYNT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 228,578 | $2.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded JYNT yet.
